CLINICAL_TRIALS
trial_result
· 2009-12-07
Clinical Trial Update: Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease [Phase 4]
Summary
Phase 4 trial evaluates memantine for improving functional communication in Alzheimer's disease, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2009-12-07